Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 769

1.

Subscapularis structural integrity and function after arthroscopic Latarjet procedure at a minimum 2-year follow-up.

Valencia M, Fernández-Bermejo G, Martín-Ríos MD, Fernández-Jara J, Morcillo-Barrenechea D, Coifman-Lucena I, Foruria AM, Calvo E.

J Shoulder Elbow Surg. 2019 Aug 10. pii: S1058-2746(19)30390-8. doi: 10.1016/j.jse.2019.05.027. [Epub ahead of print]

PMID:
31409562
2.

Corrigendum to 'A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours' [Eur J Cancer 104 (November 2018) 1-8].

Gazzah A, Boni V, Soria JC, Calles A, Even C, Doger B, Mahjoubi L, Bahleda R, Ould-Kaci M, Esler A, Nazabadioko S, Calvo E.

Eur J Cancer. 2019 Jul 30. pii: S0959-8049(18)31564-8. doi: 10.1016/j.ejca.2018.12.018. [Epub ahead of print] No abstract available.

PMID:
31375258
3.

Maternal cortisol during pregnancy and offspring schizophrenia: Influence of fetal sex and timing of exposure.

Ellman LM, Murphy SK, Maxwell SD, Calvo EM, Cooper T, Schaefer CA, Bresnahan MA, Susser ES, Brown AS.

Schizophr Res. 2019 Jul 22. pii: S0920-9964(19)30265-8. doi: 10.1016/j.schres.2019.07.002. [Epub ahead of print]

PMID:
31345704
4.

Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.

Herbst RS, Arkenau HT, Santana-Davila R, Calvo E, Paz-Ares L, Cassier PA, Bendell J, Penel N, Krebs MG, Martin-Liberal J, Isambert N, Soriano A, Wermke M, Cultrera J, Gao L, Widau RC, Mi G, Jin J, Ferry D, Fuchs CS, Petrylak DP, Chau I.

Lancet Oncol. 2019 Aug;20(8):1109-1123. doi: 10.1016/S1470-2045(19)30458-9. Epub 2019 Jul 10.

PMID:
31301962
5.

Alcohol Consumption in Later Life and Mortality in the United States: Results from 9 Waves of the Health and Retirement Study.

Keyes KM, Calvo E, Ornstein KA, Rutherford C, Fox MP, Staudinger UM, Fried LP.

Alcohol Clin Exp Res. 2019 Aug;43(8):1734-1746. doi: 10.1111/acer.14125. Epub 2019 Jul 5.

PMID:
31276233
6.

Microanalytical Study of Ancient Gold Jewelry: Mediterranean Impact on the Early Iron Age Technology in Southwestern Iberia.

Valério P, Silva RJC, Soares AMM, Fátima Araújo M, Baptista L, Calvo E.

Microsc Microanal. 2019 Aug;25(4):1061-1073. doi: 10.1017/S1431927619014582. Epub 2019 Jul 5.

PMID:
31272524
7.

New Designs in Early Clinical Drug Development.

Mansinho A, Boni V, Miguel M, Calvo E.

Ann Oncol. 2019 Jun 20. pii: mdz191. doi: 10.1093/annonc/mdz191. [Epub ahead of print]

PMID:
31218367
8.

Stress and Salivary Telomere Length in the Second Half of Life: A Comparison of Life-course Models.

Willis M, Staudinger UM, Factor-Litvak P, Calvo E.

Adv Life Course Res. 2019 Mar;39:34-41. doi: 10.1016/j.alcr.2019.02.001. Epub 2019 Feb 12.

PMID:
31186623
9.

Proteomic markers of low and high fertility bovine spermatozoa separated by Percoll gradient.

D'Amours O, Calvo É, Bourassa S, Vincent P, Blondin P, Sullivan R.

Mol Reprod Dev. 2019 Aug;86(8):999-1012. doi: 10.1002/mrd.23174. Epub 2019 May 27.

PMID:
31134708
10.

Early Phase clinical drug development of novel agents: a changing paradigm.

de Miguel M, Calvo E.

Ann Oncol. 2019 May 22. pii: mdz165. doi: 10.1093/annonc/mdz165. [Epub ahead of print] No abstract available.

PMID:
31114864
11.

Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results.

Sharma P, Siefker-Radtke A, de Braud F, Basso U, Calvo E, Bono P, Morse MA, Ascierto PA, Lopez-Martin J, Brossart P, Rohrberg K, Mellado B, Fischer BS, Meadows-Shropshire S, Abdel Saci, Callahan MK, Rosenberg J.

J Clin Oncol. 2019 Jul 1;37(19):1608-1616. doi: 10.1200/JCO.19.00538. Epub 2019 May 17. Erratum in: J Clin Oncol. 2019 Aug 10;37(23):2094.

PMID:
31100038
12.

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

Bahleda R, Italiano A, Hierro C, Mita A, Cervantes A, Chan N, Awad M, Calvo E, Moreno V, Govindan R, Spira A, Gonzalez M, Zhong B, Santiago-Walker A, Poggesi I, Parekh T, Xie H, Infante J, Tabernero J.

Clin Cancer Res. 2019 Aug 15;25(16):4888-4897. doi: 10.1158/1078-0432.CCR-18-3334. Epub 2019 May 14.

PMID:
31088831
13.

Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease.

Hernández-Alvarez MI, Sebastián D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P, Plana N, Veiga SR, Hernández V, Vasconcelos N, Peddinti G, Adrover A, Jové M, Pamplona R, Gordaliza-Alaguero I, Calvo E, Cabré N, Castro R, Kuzmanic A, Boutant M, Sala D, Hyotylainen T, Orešič M, Fort J, Errasti-Murugarren E, Rodrígues CMP, Orozco M, Joven J, Cantó C, Palacin M, Fernández-Veledo S, Vendrell J, Zorzano A.

Cell. 2019 May 2;177(4):881-895.e17. doi: 10.1016/j.cell.2019.04.010.

PMID:
31051106
14.

Clinical characteristics and prognosis for delirium in Spanish internal medicine departments: An analysis from a large clinical-administrative database.

Marco J, Méndez M, Cruz-Jentoft AJ, García Klepzig JL, Calvo E, Canora J, Zapatero A, Barba R.

Rev Clin Esp. 2019 Apr 20. pii: S0014-2565(19)30080-3. doi: 10.1016/j.rce.2019.02.005. [Epub ahead of print] English, Spanish.

PMID:
31014566
15.

Metal Nanoparticle Enhancement of Electron Transfer to Tethered Redox Centers through Self-Assembled Molecular Films.

Herrera SE, Davia FG, Williams FJ, Calvo EJ.

Langmuir. 2019 May 14;35(19):6297-6303. doi: 10.1021/acs.langmuir.9b00280. Epub 2019 May 3.

PMID:
31012590
16.

Estimation of the Allergenic Potential of Urban Trees and Urban Parks: Towards the Healthy Design of Urban Green Spaces of the Future.

Cariñanos P, Grilo F, Pinho P, Casares-Porcel M, Branquinho C, Acil N, Andreucci MB, Anjos A, Bianco PM, Brini S, Calaza-Martínez P, Calvo E, Carrari E, Castro J, Chiesura A, Correia O, Gonçalves A, Gonçalves P, Mexia T, Mirabile M, Paoletti E, Santos-Reis M, Semenzato P, Vilhar U.

Int J Environ Res Public Health. 2019 Apr 15;16(8). pii: E1357. doi: 10.3390/ijerph16081357.

17.

SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity.

Keiran N, Ceperuelo-Mallafré V, Calvo E, Hernández-Alvarez MI, Ejarque M, Núñez-Roa C, Horrillo D, Maymó-Masip E, Rodríguez MM, Fradera R, de la Rosa JV, Jorba R, Megia A, Zorzano A, Medina-Gómez G, Serena C, Castrillo A, Vendrell J, Fernández-Veledo S.

Nat Immunol. 2019 May;20(5):581-592. doi: 10.1038/s41590-019-0372-7. Epub 2019 Apr 8.

PMID:
30962591
18.

Most coronoid fractures and fracture-dislocations with no radial head involvement can be treated nonsurgically with elbow immobilization.

Foruria AM, Gutiérrez B, Cobos J, Haeni DL, Valencia M, Calvo E.

J Shoulder Elbow Surg. 2019 Jul;28(7):1395-1405. doi: 10.1016/j.jse.2019.01.005. Epub 2019 Apr 5.

PMID:
30956143
19.

Steroid Hormone Function Controls Non-competitive Plasmodium Development in Anopheles.

Werling K, Shaw WR, Itoe MA, Westervelt KA, Marcenac P, Paton DG, Peng D, Singh N, Smidler AL, South A, Deik AA, Mancio-Silva L, Demas AR, March S, Calvo E, Bhatia SN, Clish CB, Catteruccia F.

Cell. 2019 Apr 4;177(2):315-325.e14. doi: 10.1016/j.cell.2019.02.036. Epub 2019 Mar 28.

PMID:
30929905
20.

Mercury levels in blood, urine and hair in a nation-wide sample of Spanish adults.

Castaño A, Pedraza-Díaz S, Cañas AI, Pérez-Gómez B, Ramos JJ, Bartolomé M, Pärt P, Soto EP, Motas M, Navarro C, Calvo E, Esteban M; Bioambient.es.

Sci Total Environ. 2019 Jun 20;670:262-270. doi: 10.1016/j.scitotenv.2019.03.174. Epub 2019 Mar 13.

PMID:
30903899
21.

Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands.

Balaguer FA, Mühlethaler T, Estévez-Gallego J, Calvo E, Giménez-Abián JF, Risinger AL, Sorensen EJ, Vanderwal CD, Altmann KH, Mooberry SL, Steinmetz MO, Oliva MÁ, Prota AE, Díaz JF.

Int J Mol Sci. 2019 Mar 20;20(6). pii: E1392. doi: 10.3390/ijms20061392.

22.

Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer.

Calvo E, Lee JS, Kim SW, Moreno V, deCastro Carpeno J, Weilert D, Laus G, Mann H, Vishwanathan K.

J Clin Pharmacol. 2019 Aug;59(8):1099-1109. doi: 10.1002/jcph.1403. Epub 2019 Mar 15.

PMID:
30875094
23.

An insight into the sialotranscriptome and virome of Amazonian anophelines.

Scarpassa VM, Debat HJ, Alencar RB, Saraiva JF, Calvo E, Arcà B, Ribeiro JMC.

BMC Genomics. 2019 Mar 4;20(1):166. doi: 10.1186/s12864-019-5545-0.

24.

GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer.

Perez-Fidalgo JA, Iglesias M, Bohn U, Calvo E, Garcia Y, Guerra E, Manso L, Santaballa A, Gonzalez-Martin A.

Future Sci OA. 2019 Jan 10;5(2):FSO370. doi: 10.4155/fsoa-2018-0107. eCollection 2019 Feb. Review.

25.

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors.

Jung KH, LoRusso P, Burris H, Gordon M, Bang YJ, Hellmann MD, Cervantes A, de Olza MO, Marabelle A, Hodi FS, Ahn MJ, Emens LA, Barlesi F, Hamid O, Calvo E, McDermott D, Soliman H, Rhee I, Lin R, Pourmohamad T, Suchomel J, Tsuhako A, Morrissey K, Mahrus S, Morley R, Pirzkall A, Davis SL.

Clin Cancer Res. 2019 Jun 1;25(11):3220-3228. doi: 10.1158/1078-0432.CCR-18-2740. Epub 2019 Feb 15.

PMID:
30770348
26.

Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2019 Feb;566(7745):E11-E12. doi: 10.1038/s41586-019-0974-0.

PMID:
30755741
27.

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.

Hellmann MD, Callahan MK, Awad MM, Calvo E, Ascierto PA, Atmaca A, Rizvi NA, Hirsch FR, Selvaggi G, Szustakowski JD, Sasson A, Golhar R, Vitazka P, Chang H, Geese WJ, Antonia SJ.

Cancer Cell. 2019 Feb 11;35(2):329. doi: 10.1016/j.ccell.2019.01.011. No abstract available.

PMID:
30753829
28.

The structure and function of Iristatin, a novel immunosuppressive tick salivary cystatin.

Kotál J, Stergiou N, Buša M, Chlastáková A, Beránková Z, Řezáčová P, Langhansová H, Schwarz A, Calvo E, Kopecký J, Mareš M, Schmitt E, Chmelař J, Kotsyfakis M.

Cell Mol Life Sci. 2019 May;76(10):2003-2013. doi: 10.1007/s00018-019-03034-3. Epub 2019 Feb 12.

PMID:
30747251
29.

Tissue on the Transferred Coracoid Graft After Latarjet Procedure: Histological and Morphological Findings.

Haeni DL, Lafosse T, Haggerty C, Plath J, Kida Y, Sanchez-Brass M, Wolf F, Calvo E, Müller AM, Barbero A, Lafosse L.

Am J Sports Med. 2019 Mar;47(3):704-712. doi: 10.1177/0363546518819825. Epub 2019 Feb 4.

PMID:
30716278
30.

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE).

Machiels JP, Salazar R, Rottey S, Duran I, Dirix L, Geboes K, Wilkinson-Blanc C, Pover G, Alvis S, Champion B, Fisher K, McElwaine-Johnn H, Beadle J, Calvo E.

J Immunother Cancer. 2019 Jan 28;7(1):20. doi: 10.1186/s40425-019-0510-7.

31.

Identification of six cardiovascular risk biomarkers in the young population: A promising tool for early prevention.

Martínez PJ, Baldán-Martín M, López JA, Martín-Lorenzo M, Santiago-Hernández A, Agudiez M, Cabrera M, Calvo E, Vázquez J, Ruiz-Hurtado G, Vivanco F, Ruilope LM, Barderas MG, Alvarez-Llamas G.

Atherosclerosis. 2019 Mar;282:67-74. doi: 10.1016/j.atherosclerosis.2019.01.003. Epub 2019 Jan 14.

PMID:
30690299
32.

Planning to reduce 30-day adverse events after discharge of frail elderly patients with acute heart failure: design and rationale for the DEED FRAIL-AHF trial.

Martín-Sánchez FJ, Llopis García G, Llorens P, Jacob J, Herrero P, Gil V, Pastor AJ, López-Picado A, Fuentes Ferrer M, Rosselló X, Gil P, Díez Villanueva P, Calvo E, Méndez Bailón M, Cuesta-Triana F, González Armengol JJ, González Del Castillo J, Runtkle I, Vidán MT, Comín-Colet J, Cruz Jentoft A, Bueno H, Miró Ò, Fernández Pérez C.

Emergencias. 2019 Ene;31(1):27-35. English, Spanish.

33.

Associations of multiple exposures to persistent toxic substances with the risk of hyperuricemia and subclinical uric acid levels in BIOAMBIENT.ES study.

Arrebola JP, Ramos JJ, Bartolomé M, Esteban M, Huetos O, Cañas AI, López-Herranz A, Calvo E, Pérez-Gómez B, Castaño A; BIOAMBIENT.ES.

Environ Int. 2019 Feb;123:512-521. doi: 10.1016/j.envint.2018.12.030. Epub 2019 Jan 5.

34.

Rotator cuff repair is more painful than other arthroscopic shoulder procedures.

Calvo E, Torres MD, Morcillo D, Leal V.

Arch Orthop Trauma Surg. 2019 May;139(5):669-674. doi: 10.1007/s00402-018-3100-0. Epub 2018 Dec 17.

PMID:
30560289
35.

Aging and Health Policies in Chile: New Agendas for Research.

Thumala D, Kennedy BK, Calvo E, Gonzalez-Billault C, Zitko P, Lillo P, Villagra R, Ibáñez A, Assar R, Andrade M, Slachevsky A.

Health Syst Reform. 2017 Oct 2;3(4):253-260. doi: 10.1080/23288604.2017.1353844.

PMID:
30359182
36.

Mechanisms Underlying the Regulation of HP1γ by the NGF-PKA Signaling Pathway.

Seo S, Mathison A, Grzenda A, Podratz J, Calvo E, Brimijoin S, Windebank A, Iovanna J, Lomberk G, Urrutia R.

Sci Rep. 2018 Oct 10;8(1):15077. doi: 10.1038/s41598-018-33475-y.

37.

A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.

Gazzah A, Boni V, Soria JC, Calles A, Even C, Doger B, Mahjoubi L, Bahleda R, Ould-Kaci M, Esler A, Nazabadioko S, Calvo E.

Eur J Cancer. 2018 Nov;104:1-8. doi: 10.1016/j.ejca.2018.07.011. Epub 2018 Oct 1. Erratum in: Eur J Cancer. 2019 Jul 30;:.

PMID:
30278378
38.

Design and conduct of early clinical studies of immunotherapy agent combinations: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies.

Smoragiewicz M, Bogaerts J, Calvo E, Marabelle A, Perrone A, Seymour L, Shalabi A, Siu LL, Tabernero J, Giaccone G; task force on Methodology for the Development of Innovative Cancer Therapies.

Ann Oncol. 2018 Nov 1;29(11):2175-2182. doi: 10.1093/annonc/mdy398.

PMID:
30202892
39.

Optimization of sand fly embryo microinjection for gene editing by CRISPR/Cas9.

Martin-Martin I, Aryan A, Meneses C, Adelman ZN, Calvo E.

PLoS Negl Trop Dis. 2018 Sep 4;12(9):e0006769. doi: 10.1371/journal.pntd.0006769. eCollection 2018 Sep.

40.

The Current and Evolving Landscape of First-Line Treatments for Advanced Renal Cell Carcinoma.

Calvo E, Porta C, Grünwald V, Escudier B.

Oncologist. 2019 Mar;24(3):338-348. doi: 10.1634/theoncologist.2018-0267. Epub 2018 Aug 29. Review.

PMID:
30158285
41.

Frailty in elderly patients undergoing primary percutaneous coronary intervention.

Calvo E, Teruel L, Rosenfeld L, Guerrero C, Romero M, Romaguera R, Izquierdo S, Asensio S, Andreu-Periz L, Gómez-Hospital JA, Ariza-Solé A.

Eur J Cardiovasc Nurs. 2019 Feb;18(2):132-139. doi: 10.1177/1474515118796836. Epub 2018 Aug 29.

PMID:
30156426
42.

The cristae modulator Optic atrophy 1 requires mitochondrial ATP synthase oligomers to safeguard mitochondrial function.

Quintana-Cabrera R, Quirin C, Glytsou C, Corrado M, Urbani A, Pellattiero A, Calvo E, Vázquez J, Enríquez JA, Gerle C, Soriano ME, Bernardi P, Scorrano L.

Nat Commun. 2018 Aug 24;9(1):3399. doi: 10.1038/s41467-018-05655-x.

43.

[A disseminated strongyloidiasis in a non immunocompromised patient].

Duquenne J, Mabalukwa J, Calvo E, Michaux C, Staub T.

Rev Med Liege. 2018 Jul;73(7-8):383-386. French.

44.

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.

Janjigian YY, Bendell J, Calvo E, Kim JW, Ascierto PA, Sharma P, Ott PA, Peltola K, Jaeger D, Evans J, de Braud F, Chau I, Harbison CT, Dorange C, Tschaika M, Le DT.

J Clin Oncol. 2018 Oct 1;36(28):2836-2844. doi: 10.1200/JCO.2017.76.6212. Epub 2018 Aug 15. Erratum in: J Clin Oncol. 2019 Feb 10;37(5):443.

45.

A scoping systematic review of social stressors and various measures of telomere length across the life course.

Willis M, Reid SN, Calvo E, Staudinger UM, Factor-Litvak P.

Ageing Res Rev. 2018 Nov;47:89-104. doi: 10.1016/j.arr.2018.07.006. Epub 2018 Jul 23.

PMID:
30048807
46.

Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission.

Canepa GE, Molina-Cruz A, Yenkoidiok-Douti L, Calvo E, Williams AE, Burkhardt M, Peng F, Narum D, Boulanger MJ, Valenzuela JG, Barillas-Mury C.

NPJ Vaccines. 2018 Jul 10;3:26. doi: 10.1038/s41541-018-0065-5. eCollection 2018.

47.

Electrical Impedance to Assess Facial Nerve Proximity During Robotic Cochlear Implantation.

Anso J, Balmer TW, Jegge Y, Kalvoy H, Bell BJ, Dur C, Calvo EM, Williamson TM, Gerber N, Ferrario D, Forterre F, Buchler P, Stahel A, Caversaccio MD, Weber S, Gavaghan KA.

IEEE Trans Biomed Eng. 2019 Jan;66(1):237-245. doi: 10.1109/TBME.2018.2830303. Epub 2018 Apr 27.

PMID:
29993441
48.

From Snapshots to Movies: The Association Between Retirement Sequences and Aging Trajectories in Limitations to Perform Activities of Daily Living.

Azar A, Staudinger UM, Slachevsky A, Madero-Cabib I, Calvo E.

J Aging Health. 2019 Feb;31(2):293-321. doi: 10.1177/0898264318782096. Epub 2018 Jun 28.

PMID:
29952242
49.

Comprehensive Quantification of the Modified Proteome Reveals Oxidative Heart Damage in Mitochondrial Heteroplasmy.

Bagwan N, Bonzon-Kulichenko E, Calvo E, Lechuga-Vieco AV, Michalakopoulos S, Trevisan-Herraz M, Ezkurdia I, Rodríguez JM, Magni R, Latorre-Pellicer A, Enríquez JA, Vázquez J.

Cell Rep. 2018 Jun 19;23(12):3685-3697.e4. doi: 10.1016/j.celrep.2018.05.080.

50.

Francisella marina sp. nov., Etiologic Agent of Systemic Disease in Cultured Spotted Rose Snapper (Lutjanus guttatus) in Central America.

Soto E, Griffin MJ, Morales JA, Calvo EB, de Alexandre Sebastião F, Porras AL, Víquez-Rodríguez X, Reichley SR, Rosser TG, Ware C, Byrne BA, García JC, LaFrentz BR, Camus AC.

Appl Environ Microbiol. 2018 Aug 1;84(16). pii: e00144-18. doi: 10.1128/AEM.00144-18. Print 2018 Aug 15.

Supplemental Content

Support Center